TORONTO, December 30, 2025--(BUSINESS WIRE)--Cybin Inc. (NYSE American:CYBN) (Cboe Canada CA:CYBN) ("Cybin" or the "Company"), a clinical-stage breakthrough neuropsychiatry company committed to ...
The program will remain effective until either all shares are issued and sold or until October 17, 2027, unless terminated earlier. The ATM program was established through a distribution agreement ...
TORONTO, Dec. 22, 2025 (GLOBE NEWSWIRE) -- Brookfield Global Infrastructure Securities Income Fund (the “Fund”) (TSX: BGI.UN) is pleased to announce that it is renewing its at-the-market equity ...
Inhibikase Therapeutics ( (IKT)) has shared an announcement. On December 19, 2025, Inhibikase Therapeutics, Inc. filed a prospectus supplement with the U.S. Securities and Exchange Commission to ...
SAB Biotherapeutics ( (SABS)) has provided an update. On December 29, 2025, SAB Biotherapeutics, Inc. entered into a new sales agreement with UBS Securities LLC to establish an at-the-market equity ...
Strategy Inc (NASDAQ:MSTR) reported Monday that during the week of December 15 to December 21, it did not sell any shares under its at-the-market (ATM) offering program for its listed securities. The ...
NXG NextGen Infrastructure Income Fund of Benef Interest ( (NXG)) has issued an update. On December 30, 2025, NXG NextGen Infrastructure Income Fund entered into a distribution agreement with Foreside ...
ATLANTA--(BUSINESS WIRE)--Volato Group, Inc. (the “Company” or “Volato”) (NYSE American: SOAR), today announced that it has elected to pause its at-the-market equity offering program (“ATM”) through ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback